Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael G Alexandrakis

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
ISRN Hematology|November 16, 2011
Coexistence of plasma cell dyscrasia with prefibrotic stage of primary myelofibrosis: a case reportGeorge Tsirakis, Peggy Kanellou, Maria Kaparou, et al.
Journal of Hepatology|October 22, 2003
Hemopoietic progenitor cells and bone marrow stromal cells in patients with autoimmune hepatitis type 1 and primary biliary cirrhosisDespina S Kyriakou, Michael G Alexandrakis, Kalliopi Zachou, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 20, 2007
Relationship between serum levels of vascular endothelial growth factor, hepatocyte growth factor and matrix metalloproteinase-9 with biochemical markers of bone disease in multiple myelomaMichael G Alexandrakis, Aikaterini Sfiridaki, Spiros Miyakis, et al.
Pathology Oncology Research : POR|March 7, 2015
Interleukin-10 Induces Both Plasma Cell Proliferation and Angiogenesis in Multiple MyelomaMichael G Alexandrakis, Nektaria Goulidaki, Constantina A Pappa, et al.
Medical Oncology (Northwood, London, England)|April 15, 2014
Circulating levels of soluble Fas ligand reflect disease progression in multiple myelomaMichael G Alexandrakis, Constantina A Pappa, Anna Kolovou, et al.
Journal of Cancer Research and Clinical Oncology|June 8, 2014
Prognostic impact of angiopoietin-2 in multiple myelomaConstantina A Pappa, Michael G Alexandrakis, Anna Boula, et al.
Cancer Investigation|March 5, 2015
Mast cells influence the proliferation rate of myeloma plasma cellsConstantina A Pappa, George Tsirakis, Emilia Stavroulaki, et al.
Cancer Investigation|June 14, 2013
Serum levels of angiopoietin-2 are associated with the growth of multiple myelomaConstantina A Pappa, George Tsirakis, Panagiotis Samiotakis, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 9, 2002
Evaluation of bone disease in multiple myeloma: a correlation between biochemical markers of bone metabolism and other clinical parameters in untreated multiple myeloma patientsMichael G Alexandrakis, Freda H Passam, Niki Malliaraki, et al.
Clinical Therapeutics|January 8, 2016
Correlation of Mast Cell Density With Angiogenic Cytokines in Patients With Active Multiple MyelomaRodanthi Vyzoukaki, George Tsirakis, Constantina A Pappa, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
ISRN Hematology|November 16, 2011
Coexistence of plasma cell dyscrasia with prefibrotic stage of primary myelofibrosis: a case reportGeorge Tsirakis, Peggy Kanellou, Maria Kaparou, et al.
Journal of Hepatology|October 22, 2003
Hemopoietic progenitor cells and bone marrow stromal cells in patients with autoimmune hepatitis type 1 and primary biliary cirrhosisDespina S Kyriakou, Michael G Alexandrakis, Kalliopi Zachou, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 20, 2007
Relationship between serum levels of vascular endothelial growth factor, hepatocyte growth factor and matrix metalloproteinase-9 with biochemical markers of bone disease in multiple myelomaMichael G Alexandrakis, Aikaterini Sfiridaki, Spiros Miyakis, et al.
Pathology Oncology Research : POR|March 7, 2015
Interleukin-10 Induces Both Plasma Cell Proliferation and Angiogenesis in Multiple MyelomaMichael G Alexandrakis, Nektaria Goulidaki, Constantina A Pappa, et al.
Medical Oncology (Northwood, London, England)|April 15, 2014
Circulating levels of soluble Fas ligand reflect disease progression in multiple myelomaMichael G Alexandrakis, Constantina A Pappa, Anna Kolovou, et al.
Journal of Cancer Research and Clinical Oncology|June 8, 2014
Prognostic impact of angiopoietin-2 in multiple myelomaConstantina A Pappa, Michael G Alexandrakis, Anna Boula, et al.
Cancer Investigation|March 5, 2015
Mast cells influence the proliferation rate of myeloma plasma cellsConstantina A Pappa, George Tsirakis, Emilia Stavroulaki, et al.
Cancer Investigation|June 14, 2013
Serum levels of angiopoietin-2 are associated with the growth of multiple myelomaConstantina A Pappa, George Tsirakis, Panagiotis Samiotakis, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 9, 2002
Evaluation of bone disease in multiple myeloma: a correlation between biochemical markers of bone metabolism and other clinical parameters in untreated multiple myeloma patientsMichael G Alexandrakis, Freda H Passam, Niki Malliaraki, et al.
Clinical Therapeutics|January 8, 2016
Correlation of Mast Cell Density With Angiogenic Cytokines in Patients With Active Multiple MyelomaRodanthi Vyzoukaki, George Tsirakis, Constantina A Pappa, et al.
Pageof 6